In the ENRICH trial of minimally invasive cerebral hematoma removal within 24 hours after onset of hemorrhage, functional outcomes were better with surgery than with medical treatment, particularly among patients with lobar hemorrhages. Full results: nej.md/3VPYggf

#STROKE: Angioedema is rare after tenecteplase administration. This Illustrative Teaching Case showcases the emergency management of this condition and outlines the possibility of using icatibant, ecallantide, or C1 esterase inhibition. ahajournals.org/doi/10.1161/ST… @ED_PharmD21

Let’s talk through some preliminary ANNEXA-I results! What questions do you still want answered?

Cavs in 7

#JournalWatch Neurocritical Care Is ketamine your thing? Check this case series from adding data demonstrating relative safety of ketamine for SE in non-intubated patients. 71.4% deemed responders with no need for intubation. #critPRN buff.ly/3W1sRYk

Oh my... The time has arrived! ANNEXA-I has been published Time to dig in... nejm.org/doi/full/10.10…

This!!! This is such a pet peeve of mine. I get it, statins are great. The patient with endocarditis/dissection/carotid web/paradoxical embolism + stroke doesn’t need a statin. SPARCL doesn’t mean statin for everyone.

Don’t miss the first #NCS2024 poster session this afternoon! Great opportunity to connect, share insights, and explore innovations in advancing care for Neurocritical Care Society patients. 📍 Grand Hall 🕓 4–5 PM

great abstract by Andy Webb & colleagues 🧠 changing my perspective on VPA levels in the neuro icu!

SHERIF MAHMOUD discusses pharmacotherapy considerations in precision medicine at the Neurocritical Care Society Annual Meeting. #NCS2024 #NCSPharmacy

Happy PHARMACY week 💊🫶🏼🥳Cleveland Clinic Stephanie Bass Katrina Mann Stephanie Lombardi Ciapala

Looking to join our newest residency program and be a part in 1 of only 3 PGY2 Neurology programs in the country?! Sign up to meet virtually with our RPD, Grace Conroy, PharmD and stop by our booth on Monday afternoon at the ASHP Residency Showcase to learn more! #Neurology #PGY2

Sign up for a virtual interview for our new PGY2 Neurology program! 🧠💊

📣 Proud to share this publication on our Post Neuro ICU Virtual Clinic (PREVAIL) pharmacist experience! We highlight a unique way to address the unmet needs of survivors from a critical neurological injury. pubmed.ncbi.nlm.nih.gov/39672602/

New Neurocritical Care Society care society guideline: Sz ppx for nontraumatic #ICH. Panel suggests AGAINST use of ppx ASM for nontraumatic ICH and if ASM started, rec LEV for ≤ 7 days (as opposed to PHT/fPHT). rdcu.be/d5SQA Neurocritical Care University of Maryland Neurocritical Care Maryland Neurosurgery

Excited to share our work published in Clinical Neuropharmacology describing adverse hemodynamic effects and clinical outcomes of a high dose midazolam protocol in patients with RSE. 🧠 Grace Conroy, PharmD Adam Barron, MD Danielle Marut, PharmD, BCCCP journals.lww.com/clinicalneurop…

Fascinating Neurocritical Care session - with Neuro Rapid Response Teams, multimodal monitoring EEG in the NICU, BP control in ICH, discussions and debate - at the Cleveland Clinic MD Cerebrovascular Center Innovations in Cerebrovascular Care Conference ccfcme.org/iicc

Time-to-treatment for patients with ICH is significantly longer than for patients with AIS. Faster antihypertensive treatment times are associated with better discharge outcomes in patients with ICH. 🧠 shorturl.at/qEjWv #SCCMNeuro #NeuroICU #NeuroTwitter #NeuroX